Related Experiment Video

Updated: Aug 11, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection
06:11

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Population meta-analysis of low plasma glucose thresholds in full-term normal newborns

Arie L Alkalay1, Harvey B Sarnat, Laura Flores-Sarnat

  • 1Division of Neonatology, Department of Pediatrics, Ahmanson Pediatric Center, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

American Journal of Perinatology
|March 1, 2006
PubMed

Insights

Defining low plasma glucose is crucial for newborns. This study establishes specific glucose thresholds for full-term infants in the first 72 hours to aid in diagnosing neonatal hypoglycemia.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Pediatrics

Background:

  • Existing definitions for low plasma glucose in newborns vary widely, creating diagnostic challenges.
  • Lack of standardized thresholds complicates the timely identification and management of neonatal hypoglycemia.

Purpose of the Study:

  • To establish statistically defined low plasma glucose thresholds (≤ 5th percentile) for healthy, full-term newborns.
  • To provide evidence-based glucose level guidelines for the initial 72 hours of postnatal life.

Main Methods:

  • A population meta-analysis of published studies on neonatal hypoglycemia, identified via MedLine search.
  • One-way analysis of variance was used to determine the 5th percentile for plasma glucose across four postnatal time intervals.

Main Results:

  • The study identified the following ≤ 5th percentile plasma glucose levels: ≤ 28 mg/dL (1-2 hours), ≤ 40 mg/dL (3-23 hours), ≤ 41 mg/dL (24-47 hours), and ≤ 48 mg/dL (48-72 hours).
  • Recommended thresholds for neonatal hypoglycemia are 28 mg/dL (1-2 hours), 40 mg/dL (3-47 hours), and 48 mg/dL (48-72 hours).

Conclusions:

  • The proposed glucose thresholds offer a standardized, statistically derived definition for neonatal hypoglycemia.
  • Adoption of these thresholds can improve the consistency of diagnosing and managing low blood glucose in newborns.

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...